2024 Q2 Milestones

[cppoly]

Expected milestones in Q2 are:

-    Afrezza Inhale 3: 17 week top line data to be released at ADA
-    MNKD-101 (clofazimine) ICoN-1: Phase 3 global trial to be initiated
-    MNKD-201 (nintedanib): Phase 1 study to be initiated
-    Tyvaso DPI: New spray drying capacity 

Hope some of these are press release worthy

[veritasfiliatemporis]

Do you know what happened with the last 3 milestones 2024 Q1?

[ktim]

Apr 18, 2024 12:10:53 GMT -5 veritasfiliatemporis said:

Do you know what happened with the last 3 milestones 2024 Q1?


View Attachment

First meal dosing was a nutrition shake.  I'm thinking those trial participants were probably disappointed... to update an old commercial, "Where's the Wagyu?"